Evidax Information

Evidax helps biotech and pharma build evidence packages for regulatory, reimbursement, and commercial success. We specialise in generating comparative evidence when head-to-head data are limited. Either your pivotal evidence comes from a single-arm trial, or randomised data exists but not against the treatments patients actually receive. We identify what evidence your asset is missing and build one multi-purpose plan laying out what evidence to generate, how and when to generate it, and what decision it informs. A single development programme, designed well, can satisfy regulators, HTA bodies, payers, clinicians, and patients at once. Most are not designed that way. We then use advanced methods and workflows to generate new evidence from data that already exists, in weeks instead of months. We do this using Evidax TRACE™, our in-house, AI-augmented, human-in-the-loop evidence synthesis workflow, purpose-built for drug development. The end result is a robust evidence package, combining your pivotal trial data with external evidence, that holds up to external scrutiny. Our evidence generation methods include systematic reviews and meta-analyses, population-adjusted indirect comparisons, network meta-analysis, multilevel network meta-regression, historical and external controls, cost-effectiveness inputs for HTA submissions, and post-marketing safety synthesis. We work to outcomes, not hours. We agree an outcome and a price from the outset, then work with you until that outcome is delivered, with no additional charges.